UnknownNot Applicable

Effect of Enhanced External Counterpulsation on Lower Urinary Tract Symptoms

China120 participantsStarted 2013-04

Plain-language summary

The purpose of this study is to access the effects of Enhanced External Counterpulsation treatment on lower urinary tract symptoms in patients with benign prostatic hyperplasia.

Who can participate

Age range18 Years – 90 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. men over 18 years old;
✓. provide signed informed consent;
✓. existence of lower urinary tract symptoms
✓. agree not to use any lower urinary tract symptoms treatment at least one month;
✓. suitable for receiving EECP treatment

Exclusion criteria

✕. history of long drug abuse;
✕. pelvic, spine, brain trauma or surgery;
✕. endocrine, liver, lung, kidney disease, malignancies, hematological disorders;
✕. Severe infection without effective control；
✕. lower limbs deep vein thrombosis；
✕. Large area of ulcerative rash；
✕. unsuitable for receiving EECP treatment

What they're measuring

Change from baseline in lower urinary tract symptoms evaluated by International Prostate Symptom Score

Timeframe: 7 weeks

Trial details

NCT IDNCT01815697

SponsorFirst Affiliated Hospital, Sun Yat-Sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-04

Contact for this trial

Yadong Zhang, M. D.

862087755766 zhyadong@mail.sysu.edu.cn

View on ClinicalTrials.gov More Lower Urinary Tract Symptoms trials